Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers — *OTI-15-01

Chronic Diabetic Foot Ulcers Clinical Trial

Official title:
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers

Status Terminated

Clinical Trial Summary

A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02571738
Study type	Interventional
Source	Osiris Therapeutics
Contact
Status	Terminated
Phase	Phase 3
Start date	October 2015
Completion date	June 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04457752` - Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)	Phase 4
Completed	`NCT00632008` - Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers	Phase 3
Recruiting	`NCT00366132` - Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers	Phase 2
Terminated	`NCT05276401` - Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer	Phase 2
Completed	`NCT03282981` - Beta Adrenergic Antagonist for the Healing of Chronic DFU	Phase 3
Completed	`NCT02098447` - Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds	N/A
Withdrawn	`NCT00954343` - Shockwave Treatment of Diabetic Foot Ulcer: Step I	N/A
Recruiting	`NCT04962139` - Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers	Phase 3